Medicxi Ventures Management (Jersey) LTD Portfolio Holdings

Medicxi Ventures Management (Jersey) LTD

  • $481 Million
  • Q3 2024

Medicxi Ventures Management (Jersey) LTD has filed its 13F form on October 15, 2024 for Q3 2024 where it was disclosed a total value porftolio of $481 Million distributed in 4 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Centessa Pharmaceuticals PLC with a value of $319M, Phathom Pharmaceuticals, Inc. with a value of $135M, Aura Biosciences, Inc. with a value of $27.1M, and Newamsterdam Pharma CO Nv Shs with a value of $0.

Examining the 13F form we can see an increase of $201M in the current position value, from $280M to 481M.

Below you can find more details about Medicxi Ventures Management (Jersey) LTD portfolio as well as his latest detailed transactions.

Portfolio value $481 Million
Healthcare: $481 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 4
  • Current Value $481 Million
  • Prior Value $280 Million
  • Filing
  • Period Q3 2024
  • Filing Date October 15, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Medicxi Ventures Management (Jersey) LTD Portfolio

Follow Medicxi Ventures Management (Jersey) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Medicxi Ventures Management (Jersey) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Medicxi Ventures Management (Jersey) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email